82 results on '"Monforte, A D’Arminio"'
Search Results
2. Predictors of low ovarian reserve in cART-treated women living with HIV
3. Prevalence and outcomes of pregnancies in women with HIV over a 20-year period
4. Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era
5. Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances
6. Serious clinical events in HIV-positive persons with chronic kidney disease
7. Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naïve HIV-infected patients
8. Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression
9. High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects
10. Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons
11. Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals
12. Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?
13. Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals
14. Deteriorating renal function and clinical outcomes in HIV-positive persons
15. Highlights on HIV eradication in 2013
16. Natural history of HIV-control since seroconversion
17. Association Between ALT Level and the Rate of Cardio/Cerebrovascular Events in HIV-Positive Individuals
18. Insurability of HIV-positive people treated with antiretroviral therapy in Europe
19. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment
20. Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events
21. Prevalence of Prolonged Amenorrhea in HIV-Infected Women
22. Exposure to Abacavir and Biomarkers of Cardiovascular Disease in HIV-1–Infected Patients on Suppressive Antiretroviral Therapy
23. Therapeutic Monitoring and Variability of Atazanavir in HIV-Infected Patients, With and Without HCV Coinfection, Receiving Boosted or Unboosted Regimens
24. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome
25. Is There Any Potential for First-Line Etravirine Use? Analysis From a Large Data Set of Antiretroviral Therapy-Naive HIV-Infected Patients Undergoing Resistance Test
26. Effect of Baseline CD4 Cell Counts on the Clinical Significance of Short-Term Immunologic Response to Antiretroviral Therapy in Individuals With Virologic Suppression
27. CD8+ Hyperactivation and Senescence Correlate With Early Carotid Intima-Media Thickness in HIV+ Patients With No Cardiovascular Disease
28. Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients
29. Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus
30. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis
31. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy
32. Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy
33. Serum α-Fetoprotein Levels Predict Early Virologic Response in HIV-Positive Subjects Treated for Chronic Hepatitis C
34. Vertebral fractures in AIDS patients within 6 months from highly active antiretroviral therapy initiation: two case reports
35. Insulin Resistance Affects Early Virologic Response in HIV-Infected Subjects Treated for Hepatitis C Infection
36. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA
37. Late Diagnosis of HIV Infection: Epidemiological Features, Consequences and Strategies to Encourage Earlier Testing
38. Determinants of Virologic and Immunologic Outcomes in Chronically HIV-Infected Subjects Undergoing Repeated Treatment Interruptions
39. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
40. Predictive Factors of Hyperhomocysteinemia in HIV-Positive Patients
41. Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon α-2b plus ribavirin
42. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
43. Regional Changes Over Time in Initial Virologic Response Rates to Combination Antiretroviral Therapy Across Europe
44. Is Moderate HIV Viremia Associated With a Higher Risk of Clinical Progression in HIV-Infected People Treated With Highly Active Antiretroviral Therapy
45. Osteoporosis in HIV-Infected Subjects: A Combined Effect of Highly Active Antiretroviral Therapy and HIV Itself?
46. Long-term antiretroviral efficacy and safety of lopinavir/ritonavir in HAART-experienced subjects: 4 year follow-up study
47. Impact of Coinfection With HIV-1 and GB Virus C in Patients Receiving a Ritonavir-Boosted HAART Regimen: A Substudy to the MaxCmin1 Trial
48. Partnership of HIV-Infected Women and Health Status
49. Interruption of Highly Active Antiretroviral Therapy in HIV Clinical Practice
50. Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.